Monday, September 28, 2015

FDA Approves New Drug Vraylar

A new antipsychotic drug that can be used to treat schizophrenia and bipolar disorder in adults has been approved by the FDA.
Vraylar belongs to a class of drugs known as atypical antipsychotics. Others in this group include Abilify (aripiprazole), Seroquel (quetiapine) and Risperdal (risperidone).

No comments:

Post a Comment